✦ LIBER ✦

Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer

✍ Scribed by Paulo M. Hoff; Everardo D. Saad; Richard Pazdur; Robert Wolff; Yvonne Lassere; Karla R. Bogaard; James L. Abbruzzese

Book ID: 111579911
Publisher: Springer US
Year: 2004
Tongue: English
Weight: 69 KB
Volume: 22
Category: Article
ISSN: 0167-6997
DOI: 10.1023/b:drug.0000026257.31142.41

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of combined irinotecan an

Phase II trial of combined irinotecan and oxaliplatin given every 3 weeks to patients with metastatic colorectal cancer

✍ Paulo M. Hoff; Robert A. Wolff; Henry Xiong; Dennie Jones; Edward Lin; Cathy Eng 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

EPIC: Phase III Trial of Cetuximab Plus

EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

✍ Sobrero, A. F.; Maurel, J.; Fehrenbacher, L.; Scheithauer, W.; Abubakr, Y. A.; L 📂 Article 📅 2008 🏛 American Society of Clinical Oncology 🌐 English ⚖ 257 KB

Cetuximab Given Every 2 Weeks plus Irino

Cetuximab Given Every 2 Weeks plus Irinotecan Is an Active and Safe Option for Previously Treated Patients with Metastatic Colorectal Cancer

✍ Roca, José-María; Alonso, Vicente; Pericay, Carles; Escudero, Pilar; Salud, Anto 📂 Article 📅 2010 🏛 S. Karger AG 🌐 English ⚖ 125 KB

A Randomized Controlled Trial of Fluorou

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

✍ Goldberg, R. M. 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 296 KB

A phase I trial of S-1 with oxaliplatin

A phase I trial of S-1 with oxaliplatin in patients with relapsed and metastatic colorectal cancer

✍ Hyeong Su Kim; Min Jae Park; Ji Eun Uhm; Yuna Lee; Hui Young Lee; Eun Mi Kang; J 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 111 KB

Combining capecitabine, oxaliplatin, and

Combining capecitabine, oxaliplatin, and gemcitabine (XELOXGEM) for colorectal carcinoma patients pretreated with irinotecan: a multicenter phase I/II trial

✍ Se Hyun Kim; Sang Joon Shin; Sun Young Kim; Se Hoon Lee; Young Suk Park; Se Hoon 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 300 KB